A Phase I, multicenter, open-label trial to evaluate the safety of talimogene laherparepvec (T-VEC) injected into liver tumors. (4th November 2015)

Record Type:: Journal Article
Title:: A Phase I, multicenter, open-label trial to evaluate the safety of talimogene laherparepvec (T-VEC) injected into liver tumors. (4th November 2015)
Main Title:: A Phase I, multicenter, open-label trial to evaluate the safety of talimogene laherparepvec (T-VEC) injected into liver tumors
Authors:: Hecht, J Randolph
Raman, Steven
Sze, Daniel Y
Lockhart, A Craig
Moss, Rebecca A
Liu, Kate
Chou, Jeffrey
Reid, Tony
Abstract:
Is Part Of:: Journal for immunotherapy of cancer. Volume 3(2015)Supplement 2
Journal:: Journal for immunotherapy of cancer
Issue:: Volume 3(2015)Supplement 2
Issue Display:: Volume 3, Issue 2 (2015)
Year:: 2015
Volume:: 3
Issue:: 2
Issue Sort Value:: 2015-0003-0002-0000
Page Start:
Page End:
Publication Date:: 2015-11-04
Subjects:: Liver Tumor -- Maximum Tolerate Dose -- Compute Tomography Guidance -- Dose Cohort -- Metastatic Liver Tumor
Cancer -- Immunotherapy -- Periodicals
Cancer -- Immunological aspects -- Periodicals
Tumors -- Immunological aspects -- Periodicals
Immunotherapy -- Periodicals
616.99406105
Journal URLs:: http://www.immunotherapyofcancer.org ↗
https://jitc.bmj.com/ ↗
http://link.springer.com/ ↗
DOI:: 10.1186/2051-1426-3-S2-P180 ↗
Languages:: English
ISSNs:: 2051-1426
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 19195.xml